Kursinformationen (Nasdaq)
- Tagestief / Hoch-
- 52W-Tief / Hoch243,170-354,460
- Jahrestief / Hoch282,210-354,460
- Volumen Intraday
Wichtigste Eigenschaften
Termine von Vertex Pharmaceuticals Inc.
- Aug3Vertex Pharmaceuticals Inc.Q2 2023 Earnings Release
- Nov1Vertex Pharmaceuticals Inc.Q3 2023 Earnings Release
Beschreibung
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Pivot-Points (Nasdaq)
- Pivot-HBOP - R3334,530 $
- Pivot-Resist - R2331,590 $
- Pivot-High - R1327,580 $
- Pivotpunkt324,640 $
- Pivot-Low - S1320,630 $
- Pivot-Support - S2317,690 $
- Pivot-LBOP - S3313,680 $
Passender Service zu Vertex Pharmaceuticals Inc.
Webinar zu Vertex Pharmaceuticals Inc.
Erhalte jetzt Zugriff auf konkrete Trading- und Investmentideen Deiner stock3-Experten mit stock3 Trademate.
Vertex Pharmaceuticals Inc. Kurse
Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
---|---|---|---|---|---|---|
VK | ||||||
VK |